The Healthy Enterprise

In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.Chapters:00:00 Introduction to Dr. Steve Schutzer and Upswing Health02:49 Dr. Schutzer's Journey in Medicine06:02 Mentorship and the Impact of Innovation in Orthopedics08:51 Creating Centers of Excellence in Joint Replacement11:55 Challenges in Healthcare and the Role of Legislation14:50 Direct Pay and Direct Primary Care Innovations18:01 Functional Medicine and Preventative Healthcare21:06 The Future of Healthcare and Entrepreneurial Medicine31:39 The Shift to Entrepreneurship32:25 Building Centers of Excellence34:48 Identifying the Ouch Moment36:12 Innovative Solutions in Orthopedics39:11 The Evolution of Orthopedic Management41:28 The Vision for Upswing44:20 Navigating Healthcare Challenges47:30 Interoperability in Healthcare51:27 The Future of Upswing55:45 The Role of Employers in Healthcare58:42 Marketing Strategies for UpswingGuest Information:Guest's Name: Steve Schutzer Guest's Title/Position: Co-Founder and Chief Medical Officer Guest's Linkedin: https://www.linkedin.com/in/steve-schutzer-md-81616125/Company / Affiliation: Upswing Health https://upswinghealth.com/Guest's Bio: Steve Schutzer is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.Takeaways:Dr. Schutzer's journey reflects the unpredictability of career paths.The importance of mentorship in shaping a physician's career.Building centers of excellence can significantly improve patient care.Healthcare challenges are often rooted in financial disincentives.Direct primary care offers a promising alternative to traditional models.Functional medicine focuses on prevention and holistic care.Upswing Health aims to provide quick access to orthopedic care.Interoperability in healthcare is crucial for better patient outcomes.The rise of early onset cancers highlights the need for preventive care.Entrepreneurship in healthcare requires resilience and adaptability.

In this episode of The Healthy Enterprise, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.Chapters:00:00 Introduction to Jessicca Rege and Sus Clinicals07:30 The Oncopig Model: Revolutionizing Cancer Research18:04 The Journey of a Mutant Pig Farmer24:51 AI in Cancer Research and Future Directions27:14 Introduction to OncoScope AI and Leadership Roles28:36 Disruptive Leadership and Questioning the Status Quo30:45 Navigating Imposter Syndrome as a CEO32:42 The Challenges of Being a Female Leader35:41 Cultivating Future Female Leaders39:03 Steering Growth at Sus Clinicals41:33 Innovative Approaches in Large Animal Research45:34 Future Outlook and Goals for Sus Clinicals49:25 Advice for Aspiring LeadersGuest Information:Guest's Name: Jessicca RegeGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jessiccarege/Company / Affiliation: Sus Clinicals https://susclinicals.com/Guest's Bio: Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.Takeaways:Jessicca Rege is passionate about transformative research in cancer.Sus Clinicals uses genetically modified pigs to advance cancer research.The Oncopig model allows for testing efficacy, safety, and metabolic effects.Cancer patients are often more knowledgeable about their conditions than expected.Jessica emphasizes the importance of empathy in patient care.The Oncopig model can replicate human cancers on demand.Precision medicine is becoming the standard in oncology.AI is being utilized in cancer research for systematic literature reviews.Jessica's journey reflects a commitment to improving patient outcomes.The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.Imposter syndrome is always going to be with us.We want to continue to build models that enable researchers.We have a hundred percent success rate in being able to induce tumors.We believe the uptake is coming in.We could sell each of our different models to a different CRO.We hope to become a profitable company by 2027.You get more nos than you get yeses.I love the impact that I'm making on the teams.

In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.Chapters:00:00 Introduction to Resolve and Medical Debt03:11 Braden's Personal Journey and Founding Resolve06:11 Navigating the Complexities of Medical Billing09:05 The Role of AI in Medical Billing Solutions12:05 Understanding Hospital Billing Practices14:47 The Impact of Medical Debt on Patients17:58 Marketing Strategies and Patient Success Stories20:53 Future Directions for Resolve22:37 Navigating Financial Aid in Healthcare25:22 The Role of a Founder and CEO30:40 Shifting Business Strategies and Messaging32:14 Future Aspirations and Goals35:25 Leadership Evolution and Team Dynamics39:34 Advice for Aspiring Founders and Co-foundersGuest Information:Guest's Name: Braden PanGuest's Title/Position: CEO and FounderGuest's Linkedin: https://www.linkedin.com/in/bradenpan/Company / Affiliation: Resolve https://www.resolvemedicalbills.com/Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.Takeaways:Medical debt is a massive issue affecting many Americans.Resolve has saved patients over $55 million on medical bills.Braden's personal experience with medical debt inspired him to start Resolve.The healthcare system is complex and often designed to confuse patients.AI is being integrated into Resolve's processes to improve efficiency.Hospitals often prefer working with Resolve to lower their collection costs.Financial aid programs exist but are underutilized by patients.Braden emphasizes the importance of having a co-founder.Leadership evolves over time, especially in a startup environment.The future of Resolve includes expanding services to address all types of debt.

In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems.Chapters:00:00 Introduction to Altius Healthcare Consulting02:46 Stephanie's Journey into Healthcare06:50 Impact of COVID-19 on Healthcare Innovation10:32 The Role of Data in Healthcare12:02 Empowering Leaders through Data14:28 Building Trust and Accountability in Leadership18:13 The Importance of Continuous Improvement in Healthcare22:31 Navigating Leadership Development30:12 The Entrepreneurial Leap37:59 Innovations in Healthcare41:14 Vision for the Future of AltiusGuest Information:Guest's Name: Stephanie DorwartGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/stephanie-dorwart/ Company/Affiliation: Altius Healthcare Consulting Group https://altiushcg.com/Guest's Bio: Stephanie Dorwart is the CEO of ALTIUS, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. Takeaways:Altius focuses on improving financial and operational performance in healthcare.Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.COVID-19 accelerated the adoption of telehealth and innovative care models.Data in healthcare is relatively new and can significantly impact productivity.Empowering leaders with data helps them make informed decisions.Building trust within teams is essential for effective leadership.Accountability starts with setting clear goals and regular check-ins.Time management is crucial for leaders to think strategically.Rural healthcare systems face unique challenges and need support.The future of healthcare may focus more on preventive care and nutrition.

In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes.Chapters:00:14 Introduction to OliveBio and Yuliana's Background02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution06:15 Understanding PHAs: A Sustainable Bioplastic Solution11:59 OliveBio's Innovative Production Process for PHAs15:57 Applications and Future of Bioplastics18:21 Yuliana's Entrepreneurial Journey and Challenges22:36 Leveraging AI and Automation in Biotech33:13 Marketing and Growth Strategy for OliveBio36:49 Vision for OliveBio's Future Impact39:43 Key Learnings and Advice for Aspiring InnovatorsGuest Information:Guest's Name: Yuliana MihaylovaGuest's Title/Position: CEO & Co-FounderGuest's Linkedin: https://www.linkedin.com/in/yulianamihaylova/Company / Affiliation: OliveBio https://olivebio.com/Guest's Bio: Yuliana Mihaylova is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy.Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.Takeaways:OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollutionFocuses on PHAs, biodegradable polymers from renewable sources that leave no microplasticsUses enzyme-based production instead of bacterial fermentation for better precision and lower costsPHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like suturesYuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resourcesAI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracyMarketing strategy targets B2B2C—engaging businesses and influencing consumer demandLong-term vision is to build a sustainable, impactful company rather than seeking early acquisition

In this episode of the Healthy Enterprise podcast, David Georges, North American president of Koning Health, discusses his extensive experience in the breast imaging industry and the innovative BreastCT technology. He shares insights into the challenges of traditional mammography, the importance of early detection, and the potential of BreastCT to revolutionize breast cancer screening. The conversation also touches on the integration of AI, the global market expansion of the technology, and the significance of mentorship and leadership in driving change within healthcare.Chapters:00:00 Introduction to Breast Imaging Innovations02:49 David Georges' Journey in Breast Cancer Detection06:02 The Evolution of Breast Imaging Technology08:54 Challenges in Mammography and Patient Compliance11:58 Commercialization of BreastCT Technology14:46 Navigating Change in Medical Imaging18:11 Global Expansion and Future Vision for Koning Health20:45 The Impact of BreastCT on Patient Experience23:51 Addressing Resistance and Building Trust in New Technology26:58 The Future of Breast Imaging and Biopsy Procedures30:33 Understanding the Breast Imaging Industry32:28 The Role of AI in Breast Imaging34:04 Creating Commercial Viability for New Technology36:30 Educating Radiologists on New Imaging Techniques39:18 Building Confidence in Radiologists42:10 Transitioning to New Technologies in Imaging44:57 Career Guidance in Healthcare and Technology49:42 Mobile Breast Imaging Solutions54:08 The Economic Impact of Early Detection56:34 Future Prospects for Breast Imaging TechnologyGuest Information:Guest's Name: David GeorgesGuest's Title/Position: North American PresidentGuest's Linkedin: https://www.linkedin.com/in/david-georges-48a14020/Company / Affiliation: Koning Health https://www.koninghealth.com/Guest's Bio: David Georges has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE.Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.Takeaways:David Georges has 40 years of experience in breast imaging.BreastCT technology offers true isotropic 3D imaging without compression.Early detection of breast cancer significantly improves treatment outcomes.Patient compliance with mammograms is low due to discomfort.Koning Health aims to integrate BreastCT into existing facilities easily.The technology is gaining traction in global markets, including China and Australia.AI will play a crucial role in interpreting BreastCT images.Mobile BreastCT units are being deployed to increase accessibility.Healthcare economics favor early detection to reduce treatment costs.

In this episode, Eitan Akirav shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.Chapters:00:00 Introduction to Eitan Akirav and His Journey03:13 Transitioning from Academia to Industry06:03 The Role of Mentorship in Career Development09:04 Leadership in Academia vs. Industry11:58 Innovations in Diabetes Research and Patents15:02 The Future of Diabetes Detection and Prevention17:56 The Impact of AI in Healthcare21:03 Disruptive Innovations in Life Sciences25:31 The Concept of Cure in Cancer Treatment28:09 Balancing Technology and Human Touch in Healthcare29:52 The Economic Challenges of Drug Development32:50 Advice for Newcomers in the Science Industry36:46 Challenges in Consulting and Marketing Yourself44:44 Final Thoughts and Reflections on the JourneyGuest Information:Guest's Name: Eitan Akirav Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/eitan-akirav/Company/Affiliation: KonKai Ventures https://www.linkedin.com/company/konkai-consulting/posts/?feedView=allGuest's Bio: Eitan Akirav is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in PNAS and Nature Immunology, Eitan continues to advance science at the intersection of research, innovation, and real-world application.Takeaways:Eitan Akirav has over 17 years of experience in biotech.Mentorship plays a crucial role in career transitions.The transition from academia to industry can be challenging but rewarding.Innovations in diabetes research are focused on early detection.AI is a powerful tool that can save time in healthcare.The future of oncology may involve re-engineering immune cells.Customized medications based on genetic information are on the rise.The drug approval process is lengthy and complex.Newcomers in biotech should pursue their passion, not just titles.Consulting requires effective self-marketing and client relationship management.

In this episode of The Healthy Enterprise, Dr. Josh Funk, CEO of Rehab to Perform, shares his journey from college athlete to the head of a thriving, multi-location physical therapy practice. He dives into what it takes to build a business rooted in performance, culture, and innovation—especially in the evolving healthcare space. Dr. Funk discusses strategies for leadership, employee retention, and navigating growth while staying true to core values. From adapting during the COVID-19 pandemic to embracing AI and automation, Dr. Funk emphasizes the need for transparency, adaptability, and a relentless focus on patient empowerment to stay ahead in the industry.Chapters:00:00 Introduction to Dr. Josh Funk and Rehab 2 Perform01:07 Dr. Funk's Journey: From Athlete to Entrepreneur03:48 Growth of Rehab 2 Perform: From One to Eleven Locations06:38 Leadership and Culture: Infusing Vision Across Locations12:20 Retention Strategies: Keeping the Right Talent17:07 Challenges and Learning: Navigating Business Growth20:20 Adapting to COVID-19: Innovations and Changes24:01 Balancing Process and Human Connection27:10 Innovative Service Delivery in Physical Therapy30:03 The Role of Patient Participation in Recovery35:13 Growth Strategies for Rehab 2 Perform38:07 Navigating Marketing in a Competitive Landscape40:43 Challenges in the Healthcare System43:12 Leveraging AI for Efficiency48:40 Envisioning a Better Healthcare SystemGuest Information:Guest's Name: Dr. Josh FunkGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/joshfunk/Company / Affiliation: Rehab 2 Perform https://rehab2perform.com/Guest's Bio: Dr. Josh Funk is the Founder and CEO of Rehab 2 Perform (R2P), a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal.Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? Treat people like athletes, build a better baseline, and help them perform for life.Dr. Funk also co-leads R2P Academy, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.Takeaways:Dr. Funk’s background as an athlete shapes his leadership style.Strong company culture is essential for multi-location success.Retention strategies are key when working with a young team.The pandemic accelerated innovation and adaptation.Balancing systems with human connection is critical in healthcare.Patient empowerment leads to better recovery and long-term results.Focusing on movement and performance—not just pain—is core to R2P’s approach.AI and automation can improve operations without replacing people.Transparent leadership builds alignment and trust.R2P plans to continue expanding its reach and impact.

In this conversation, Ed Fleischer shares his extensive career journey in the biotech industry, detailing his experiences from working in large pharmaceutical companies to transitioning into consultancy. He discusses the importance of staying current with industry trends, the impact of AI on biotech, and innovations in quality control. Edwin reflects on meaningful experiences that shaped his career, the significance of leadership and communication, and the motivation behind delivering life-changing medicines to patients.Chapters:0:00 - Introduction to Ed Fleischer2:09 - From Biotechnology to Consultancy10:00 - The Journey Through Major Pharma13:00 - Staying Current in a Dynamic Field14:43 - The Impact of AI on QC21:06 - The "Why" Behind the Work32:20 - Leadership and Authenticity36:51 - The Value of Public Speaking42:42 - Delivering on Trust46:11 - Conclusion and TakeawaysGuest Information:Guest's Name: Ed FleischerGuest's Title/Position: Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/ed-fleischer-a780482/Company/Affiliation: Beachside Compliance SolutionsGuest's Bio: Ed Fleischer is a seasoned Quality Control executive with a strong track record of leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. With deep expertise in biotechnology processes, quality systems, and regulatory requirements across both domestic and international markets, he has successfully collaborated with agencies such as the FDA, EMA, and others. Ed is also the CEO of Beachside Compliance Solutions, a consultancy specializing in analytical and Quality Control challenges, where he offers independent, expert guidance to organizations navigating complex regulatory environments. He is passionate about developing talent and fostering a culture of quality at all levels of an organization.Takeaways:-He transitioned to consultancy after working in various pharmaceutical companies.-Staying current with regulations and industry trends is crucial for success.-AI is becoming increasingly important in the biotech field.-Innovations in quality control are revolutionizing the industry.-Ed's impactful experience with a patient highlighted the importance of their work.-Leadership requires authenticity and the ability to communicate effectively.-Diversity in teams leads to better problem-solving and innovation.-Consultants care about the outcomes of their work and follow up with clients.-The pharmaceutical industry is driven by the need to deliver safe and effective medicines.

In this conversation, Wendy Slone, PhD, discusses her journey as an entrepreneur and the development of her company, BTEC, which focuses on innovative wound care solutions through the Halcyon Smart Patch. She emphasizes the importance of healing from within, the challenges of entrepreneurship, and the significance of building relationships and networking. Wendy also shares her insights on empowerment, particularly for women in business, and the need for a strong support system.Chapters:00:13 Introducing Dr. Wendy Sloan & B-Tech01:13 The Halcyon Smart Patch: Healing from the Inside Out02:02 The Personal Spark Behind B-Tech03:32 From NASA to Public Policy: Dr. Sloan’s Journey06:26 Far Infrared Light, Explained07:58 The Chronic Wound Care Crisis10:00 The Hidden Burden of Chronic Wounds13:51 B-Tech’s Buzz & Upcoming Human Trials15:06 Real-World Potential: Animals, Space & Defense18:53 Growing B-Tech: Early Lessons & Challenges20:07 Why Strategy Matters More Than Just the Product27:26 Building Investor Trust & Strategic Partnerships33:04 Mentorship, Boldness & Breaking Barriers36:09 Owning the Room & Overcoming Imposter Syndrome41:18 Resilience, Community & Entrepreneurial Grit43:05 Final Reflections on a Remarkable JourneyGuest Information:Guest's Name: Dr Wendy Slone Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/wendy-s-ba02b240/Company / Affiliation: bTECH https://btechls.com/Guest's Bio: Dr. Wendy Slone is the founder and CEO of bTECH Inc., where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.Takeaways:BTEC's Halcyon Smart Patch focuses on healing wounds from the inside out.Microcirculation is crucial for effective wound healing.The wound care industry is often overlooked despite its significance.Entrepreneurship involves navigating various challenges and obstacles.Building a solid business model is essential for success.Networking and building relationships are key to finding investors.Women entrepreneurs often face unique challenges and need support.It's important to maintain a positive attitude and resilience in business.Asking questions and challenging the status quo is vital for growth.Creating a core support system can significantly impact an entrepreneur's journey.

In this episode, Aimee Taylor, Founder and CEO of Alt Digital Marketing, shares her journey from traditional television marketing to the digital landscape, emphasizing the importance of strategy, authenticity, and client engagement in marketing. She discusses the evolving role of AI and SEO, the significance of human connection in marketing, and the challenges faced in healthcare marketing. Aimee also provides valuable insights for aspiring marketers, highlighting the need for hiring the right talent and the importance of transparency with clients.Chapters:00:00 Introduction to Digital Marketing and Transition from Traditional Media05:02 The Importance of Strategy in Marketing09:53 Navigating the AI Landscape in Marketing15:02 Understanding SEO and Its Evolution19:59 The Role of Websites in Modern Marketing24:47 The Role of Human Operators in Marketing25:42 Authenticity and Credibility in the Digital Age27:05 Navigating Google Business Profiles28:54 The Importance of Local SEO and Reviews30:39 The Value of Human Connection in Marketing32:58 Understanding the Client's Journey34:54 The Impact of Call Tracking on Business36:23 Healthcare Marketing: A Shift in Consumer Behavior38:51 The Future of Preventative Healthcare40:25 Adapting to AI in Marketing42:07 Leadership and Team Dynamics in Marketing46:35 Advice for Aspiring MarketersGuest Information:Guest's Name: Aimee TaylorGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/aimee-taylor/Company/Affiliation: Alt Digital Marketing https://altdigitalmarketing.com/Guest's Bio: Aimee Taylor is the Founder and CEO of Alt Digital Marketing, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.Takeaways:Digital marketing offers more trackable results compared to traditional media.Strategy is crucial in navigating the complex marketing landscape.Clients need to niche down to effectively market their services.AI is reshaping marketing, but human oversight remains essential.Authenticity and credibility are vital for successful marketing campaigns.The website serves as the foundation for all marketing efforts.Engagement with clients enhances the effectiveness of marketing strategies.Healthcare marketing is evolving towards a focus on wellness and preventative care.Effective leadership involves hiring the right people and fostering a positive team culture.

In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.00:00 Introduction to BioLogic Pharma Solutions03:01 The Fractional Model in Biotech Consulting06:00 Navigating Uncertainty in Drug Development09:04 Mary's Entrepreneurial Journey11:50 Vision for the Future of Biotech Consulting14:45 Challenges in Consulting and Growth17:57 The Importance of Trust in Entrepreneurship26:49 The Importance of Delegation in Business28:02 Navigating Client Acquisition and Marketing Strategies30:35 Effective Client Engagement and Presentation Techniques34:12 Understanding Market Dynamics and Client Feedback36:11 Identifying the Sweet Spot in the Drug Development Process39:25 Building a Flexible Workforce and Consultant Relationships40:19 Future Aspirations and Growth Strategies for the Company46:12 Reflections on the Entrepreneurial JourneyGuest Information:Guest's Name: Mary Hames Guest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/Company / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/Guest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency. Takeaways:The fractional model allows companies to access expertise without full-time hires.Building a company culture is essential for employee satisfaction.Consulting can be lonely, but teamwork helps mitigate that.Marketing strategies include presentations and SEO efforts.Trust is crucial for entrepreneurs to delegate responsibilities.The future of BioLogic includes becoming a go-to firm for pre-commercial products.Navigating uncertainty in drug development is a common challenge.Mary's entrepreneurial journey includes learning from past failures.The sweet spot for consulting is between phase two and three of drug development.

In this episode, Dr. Paula Muto shares her journey as a surgeon and entrepreneur, discussing her experiences in the medical field and the founding of UberDoc, a platform designed to provide patients with direct access to healthcare professionals. She emphasizes the importance of leadership, teamwork, and the challenges faced by women in medicine. Dr. Muto also highlights the need for innovation in healthcare and how UberDoc aims to empower patients by simplifying access to medical care.00:00 Introduction to Dr. Paula Muto and Her Journey02:33 Building the Muto Vein Center: A Personal Journey04:26 Leadership in Healthcare: Building a Strong Team07:06 Challenges in Modern Medicine: The Human Element09:38 Gender Disparities in Surgery: A Personal Perspective12:01 The Evolution of Surgical Practices and Technology12:46 Introducing UberDoc: A Solution for Patient Access15:55 The UberDoc Model: Direct Access to Care20:23 Insurance and Flexibility: The Future of Healthcare22:24 Overcoming Resistance: The Journey of UberDoc26:09 Expanding the Network: The Growth of UberDoc28:16 Streamlining Patient Appointments31:18 The Evolution of Telemedicine34:59 Building the UberDoc Team38:17 Funding and Expansion Strategies40:52 The Future of Direct Pay Healthcare45:03 Reimagining Patient CareGuest Information:Guest's Name: Paula MutoGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/paulamutomd/Company/Affiliation: UBERDOC - https://uber-docs.com/Guest's Bio: UBERDOC Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues. Takeaways:Dr. Muto comes from a long line of surgeons and is passionate about restoring healthcare.Leadership in healthcare requires understanding and flexibility with team dynamics.Women in medicine face unique challenges, including compensation disparities.The healthcare system often prioritizes billing over patient care, leading to inefficiencies.UberDoc was created to solve the problem of access to healthcare for patients.The UberDoc model allows patients to pay directly for appointments, bypassing insurance complexities.Building a strong team is crucial for the success of any healthcare venture.Direct pay models are gaining traction as a solution to healthcare access issues.The future of healthcare may involve more technology and patient empowerment.Dr. Muto encourages collaboration among healthcare professionals to improve patient outcomes.

In this episode, Heath Fletcher and Kevin Scanlon delve into the intricacies of entrepreneurship, investment, and the vital role of character and team dynamics in achieving success. They discuss the importance of mentorship, the challenges entrepreneurs face in communicating with investors, and the significance of trust in business relationships. Kevin shares insights from his extensive experience in angel investing and teaching entrepreneurship, highlighting the need for adaptability and the ability to pivot in the face of challenges. The conversation also touches on the differences in investment environments across regions and the importance of a strong team over a perfect product.00:00 Introduction and Background01:50 Navigating the Science and Business Divide05:46 The Role of Angel Investors09:51 Teaching Entrepreneurship13:38 Trust and Team Dynamics in Startups17:38 Investment Strategies and Risk Management21:14 Regional Differences in Medical Investment23:02 International Consulting and Global Perspectives25:32 Cultural Insights from Global Experiences26:59 The Shark Tank Experience: Reality vs. TV29:21 The Rigorous Selection Process for Entrepreneurs31:33 Challenges in Startup Growth and Team Dynamics33:14 Funding Roadblocks and Cultural Differences37:11 Success Stories: From Struggles to Triumphs40:53 The Future of Investment: Incubators and Mentorship44:13 The Importance of Character in Entrepreneurship46:25 Investor Perspectives on Entrepreneurial SuccessGuest Information:Guest's Name: Dr. Kevin ScanlonGuest's Title/Position: Founder & CEO of International BioScience Guest's Linkedin: https://www.linkedin.com/in/kjscanlon/Company/Affiliation: Pasadena Angels https://www.linkedin.com/company/pasadena-angels/Guest's Bio: Dr. Kevin Scanlon is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure.Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia.His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of Cancer Gene Therapy (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of The Hybrid Entrepreneur. TakeawaysCharacter is crucial for entrepreneurial success.Investors look for strong team dynamics.Mentorship can significantly impact startup growth.Understanding investor vocabulary is essential for entrepreneurs.Trust issues can hinder investor-entrepreneur relationships.A strong team can pivot and adapt to challenges.Financial strategy is often a weak point for entrepreneurs.Communication of complex ideas is vital for success.Cultural differences can create friction in teams.Success stories often come from perseverance and adaptability.

In this episode, Naomi Cosman, Global Head of Marketing and Investor Relations at Koning, discusses the revolutionary breast imaging technology offered by Koning. The conversation covers the importance of patient comfort, the challenges of industry resistance, and the need for early detection of breast cancer. Naomi shares insights on marketing strategies, the role of mobile units in increasing accessibility, and the ongoing challenges with insurance coverage. The episode emphasizes the significance of integrating marketing across departments and the passion behind working in healthcare startups.00:00 Introduction to Koning Health and Breast Imaging Innovation02:30 Revolutionizing Breast Imaging: The Koning Vera Breast CT05:47 The Importance of Early Detection and Patient Comfort10:20 Overcoming Industry Resistance and Adoption Challenges15:49 Mobile Units and Accessibility in Breast Imaging20:43 Marketing Strategies: Engaging Patients and Physicians25:57 Insurance Challenges and Cost of Exams30:22 The Startup Culture and Passion for Healthcare35:59 Balancing Technology and Human Connection in Marketing40:24 Conclusion and Call to Action for Breast Health AwarenessGuest Information:Guest's Name: Naomi CosmanGuest's Title/Position: Global Head of Marketing & Investor RelationsGuest's Linkedin: https://www.linkedin.com/in/naomicosman/ Company/Affiliation: Koning Health https://www.koninghealth.com/Guest's Bio: Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.

In this episode, Dr. Axa Yox shares her journey from biotechnology to nutrition, revealing how a deeper understanding of biochemistry, diet, and environment can unlock better health and longevity. She opens up about personal setbacks, the challenges of building a brand in the wellness space, and the critical role of educating people on the science behind nutrition. From insulin regulation to intermittent fasting and mindful eating, Axa offers practical insights to help listeners make empowered, informed decisions about their health.Chapters:00:00 Introduction to Dr. Oksa Jox02:11 Journey from Biotechnology to Nutrition04:30 Learning from Failures08:20 The Importance of Market Understanding10:07 Building a Personal Brand18:22 Explaining the Mechanisms of Healthy Eating26:32 The Role of Environment in Health30:03 Understanding Insulin and Glucose Metabolism32:56 The Importance of Intermittent Fasting36:05 Personal Health Transformations Through Diet39:02 The Misconceptions of Food Labels41:54 Building a Personal Brand in Health46:06 Future Aspirations and Growth in Health Coaching48:02 Stress Management and Breathing Techniques52:11 The Concept of Promises and Personal GrowthGuest Information:Guest's Name: Dr. Axa YoxGuest's Title/Position: Fouder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/dr-axa-yox/Company/Affiliation: X Theory Inc https://x-theory.kit.com/1e03b15cdcGuest's Bio: Dr. Axa Yox is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of X Theory, host of the W.H.Y. – What How Y podcast, and author of Foolfilled Life, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at BRAINZ Magazine, Axa brings deep scientific insight to personal development, branding, and the psychology of change.

In this episode, Len May, CEO of EndoDNA, joins Heath Fletcher to explore the future of personalized medicine through genetic testing. They dive into the challenges of innovating within the healthcare market, the role of lifestyle and genetics in preventative care, and the critical importance of understanding the endocannabinoid system. Len shares personal stories that highlight the transformative potential of precision health, the need to overcome stigma around cannabis, and the power of partnerships in driving research. The conversation also reflects on mentorship, personal influences, and how music shapes both life and work.Guest Information:Guest's Name: Len MayGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/lenmay/ Company/Affiliation: EndoDNAGuest's Bio: Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast Everything is Personal. His books Making Cannabis Personal and ADD is a Superpower highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.Links and Resources:Podcast: Everything is Personal Books: Making Cannabis Personal / ADD is a SuperpowerWebsite: https://www.lenmaycoaching.com/

In this episode, Heath Fletcher sits down with Dr. Jay Sanders, the “Father of Telemedicine,” to explore how technology is reshaping healthcare. From the early days of telemedicine to the integration of AI and electronic medical records, Dr. Sanders shares his visionary insights on the future of medicine. They discuss the economic impact on rural hospitals, the importance of cybersecurity, and why anticipatory, patient-driven care is key to the next evolution in healthcare.Chapters00:00 Introduction to Jay Sanders and Telemedicine05:05 The Evolution of Telemedicine10:02 Economic Impact of Telemedicine on Rural Healthcare15:04 The Role of AI in Medicine20:12 Current Work and Future of Telemedicine25:06 The Future of Healthcare: Anticipatory Medicine27:55 Leveraging Technology for Patient Care30:02 AI in Medical Decision Making31:59 Cybersecurity in Healthcare Data34:10 The Future of Healthcare Post-Pandemic41:01 Innovations in Telemedicine and AI45:57 The Vision for Future HealthcareGuest Information:Guest's Name: Dr. Jay H. SandersGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jay-sanders-m-d-9618771/. Company/Affiliation: The Global Telemedicine GroupGuest's Bio: Dr. Jay H. Sanders, known as the “Father of Telemedicine,” is the CEO of The Global Telemedicine Group and Adjunct Professor of Medicine at Johns Hopkins. He founded the American Telemedicine Association and pioneered numerous telemedicine innovations, including the first statewide system and telemedicine kiosk. A Harvard Medical School graduate and former Chief Medical Resident at Massachusetts General Hospital, Dr. Sanders has advised organizations like NASA, DOD, WHO, and the White House. His career spans groundbreaking work in digital health, policy, and global telemedicine strategy.Links and Resources:Co-Author of the Book Digital Medical HomeAvailable on Amazon: https://www.amazon.ca/Digital-Medical-Home-Telemedicine-Revolution/dp/B0BRDDJGKYTakeawaysThe term 'telemedicine' was coined in 1969 during a project at Massachusetts General Hospital.Telemedicine can significantly improve healthcare access in rural areas.Economic factors play a crucial role in the sustainability of rural hospitals.AI has the potential to surpass human physicians in certain areas of healthcare.The best examination of a patient occurs in their home environment.Telemedicine has evolved from using microwave antennas to modern telecommunications.COVID-19 accelerated the acceptance and payment for telemedicine services.Healthcare needs to shift from reactionary to anticipatory models.Genetic analysis should be integrated into routine healthcare practices. Leveraging technology can significantly improve patient care.AI can assist in making informed medical decisions.Cybersecurity is a critical concern for healthcare data.The pandemic has accelerated changes in healthcare delivery.Patients need to take more responsibility for their health.Telemedicine is becoming a standard practice in healthcare.Integrating genetics into healthcare can enhance treatment specificity.Healthcare systems must adapt to new technologies for better outcomes.Access to healthcare is essential, but accuracy is equally important.The future of healthcare will rely on innovative technologies and patient engagement.

In this episode, Dan Goldberger, CEO of electricCore, explores the company’s innovative use of non-invasive vagus nerve stimulation to treat conditions such as headaches, PTSD, and other medical issues. He emphasizes the strong safety profile of their technology and its potential in the growing field of bioelectronic medicine. Dan explains the foundational concept of the body’s electrical systems and how bioelectronics offer an alternative to traditional pharmaceuticals. He also shares perspectives on leadership, company culture, and the challenges of marketing in healthcare, along with thoughts on the role of AI and automation in the future of health tech and personal career insights.Special Podcast Offer: 10% truvaga discount code HEALTH1000:00Introduction to Electric Core and Its Innovations04:48Understanding Vagus Nerve Stimulation10:00The Impact of Headaches and PTSD15:02Leadership Lessons and Building Culture19:59The Future of Bio-Electronic Medicine21:06The Electrical Nature of the Human Body28:29Marketing Evolution in Healthcare33:59Navigating AI and Automation in Health Tech37:32Reflections on Career and Life LessonsGuest Information:Guest's Name: Dan GoldbergerGuest's Title/Position: Chief Executive Officerhttps://www.linkedin.com/in/goldbergerdan/Company/Affiliation: electroCoreGuest's Bio: Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. Links and Resources:electroCore Website: https://www.electrocore.com/Special Podcast Offer: 10% truvaga discount code HEALTH10Key TakeawaysThe company offers products for treating headaches and is expanding into PTSD treatment.Vagus nerve stimulation has a wide range of potential applications in medicine.The technology has a benign safety profile with minimal side effects.Leadership is about surrounding yourself with the right people and building a strong culture.Listening is a crucial skill for effective leadership and learning.Embracing change is essential for resilience in business.The future of bio-electronic medicine is promising and innovative.Dan emphasizes the importance of leading by example in building company culture.The conversation highlights the liberating potential of electricCore's products for patients. The human body operates as an electrical machine.Bioelectronics is an emerging field in healthcare.The vagus nerve plays a crucial role in balance.Stimulating the vagus nerve can restore homeostasis.Marketing in healthcare is increasingly complex.AI is not yet a strategic focus for their company.Direct consumer access to health tech is growing.Ethics and morality are vital in business.Career reflections emphasize the importance of relationships.Helping others is the core motivation in health tech.

In this conversation, Heath Fletcher and Real Rousseau explore the concept of fractional management, particularly in the context of C-suite roles. Real shares his extensive background in engineering and business management, discussing how fractional executives can provide expertise at a fraction of the cost of full-time hires. The discussion covers the benefits of fractional engagement, the differences between fractional executives and consultants, and the strategic planning processes that fractional executives can help implement. Real emphasizes the importance of structure in creativity and how fractional executives can help businesses grow by providing accountability and expertise.Chapters00:00Introduction to Fractional Management02:56The Rise of Fractional Executives05:57Benefits of Fractional C-Suite Engagement08:59Identifying the Right Time for Fractional Support11:59Strategic Planning and Implementation14:49The Role of Fractional Executives in Growth18:02Leveraging Experience Across Industries20:57Conclusion and Future of Fractional ManagementGuest Information:Guest's Name: Real RousseauGuest's Title/Position: Chief Strategy Officerhttps://www.linkedin.com/in/real-rousseau-5b150422/Company/Affiliation: Bullzeye Media MarketingGuest's Bio: Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.TakeawaysFractional management offers executive expertise at a lower cost.The rise of fractional executives coincided with the COVID-19 pandemic.Fractional executives are part of the team, unlike consultants.Hiring junior staff may not always provide the needed expertise.Fractional executives can help identify when a business needs support.Strategic planning is crucial for business growth and accountability.Fractional executives can help implement financial processes and budgeting.AI tools can assist but cannot replace the need for human expertise.Fractional roles can evolve as the business grows and changes.Collaboration between fractional executives and business owners enhances growth.

In this episode, we interview David Esposito, an experienced healthcare CEO with a background in both large pharma and early-stage biotech. David discusses his career journey, insights into leading and scaling healthcare companies, and the challenges and opportunities in developing innovative therapies for diseases of the eye. He also shares his perspective on leadership, team building, and the importance of maintaining a focus on patient outcomes.Chapters/Timestamps:00:00 - Introduction and David Esposito's Background02:09 - ONL Therapeutics and its Focus09:05 - David Esposito’s Career Journey24:47 - Leadership and Team Building32:35 - Challenges in Biotech and Company Growth48:22 - Marketing and Clinical Trial Enrollment58:52 - Funding and Future Outlook1:09:09 - Inspiration and Advice1:19:31 - The Future of Healthcare InnovationGuest Information:Guest's Name: David EspositoGuest's Title/Position: CEOCompany/Affiliation: ONL TherapeuticsGuest's Bio: David Esposito is an experienced healthcare CEO with over thirty years in the industry. He has a background in large pharma and has built and scaled multiple early to mid-stage life science companies. Currently, he is the CEO of ONL Therapeutics, a mid-stage biotech company focused on developing therapies for diseases of the eye.Links and Resources:ONL Therapeutics: https://onltherapeutics.com/RA Capital: https://www.racap.com/Andreessen Horowitz: https://a16z.com/

In this episode, we interview Dr. Alena Butkevica, an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. Dr. Butkevica shares her journey from reconstructive surgery to developing a line of skincare products designed to boost natural body regeneration and provide alternatives to invasive procedures. She discusses the science behind her products, the importance of high-quality ingredients, and her passion for helping people achieve healthy skin.Chapters/Timestamps:00:00 - Introduction and Dr. Alena Butkevica's Background 10:00 - Dr. Alena Butkevica's Career and Surgical Experience 37:00 - Explanation of Circulation and the Effects of Aging 55:00 - Development of AB Bio Products 1:20:00 - Discussion on Skincare Ingredients and Product Application 1:40:00 - The Future of AB Bio and the Importance of Marketing Guest Information:Guest's Name: Dr. Alena ButkevicaGuest's Title/Position: MD, DMD, PhD, CEO, and Lead ResearcherCompany/Affiliation: AB Bio InnovationsGuest's Bio: Dr. Alena Butkevica is an oro maxillofacial surgeon and the CEO and lead researcher at AB Bio Innovations. With a background in medical science and a passion for helping people, she has created a line of award-winning skincare products that offer scientifically proven solutions for various skin concerns.

In this episode, we interview Dr. Ethan Perlstein, founder and CEO of Curetopia, about his mission to end rare genetic diseases. Dr. Perlstein shares his journey as a scientist, builder, and investor, and discusses Curetopia's innovative approach to drug development, including the use of blockchain and Web3 technologies. He emphasizes the urgency of addressing rare diseases and the need for new models to accelerate the search for cures.Chapters/Timestamps:00:00 - Introduction and Dr. Ethan Perlstein's Background 08:50 - The Challenge of Rare Diseases 21:25 - Curetopia's Mission and Approach 31:54 - Blockchain and the Future of Drug Development 40:09 - The Future of Curetopia and Rare Disease ResearchGuest Information:Guest's Name: Dr. Ethan PerlsteinGuest's Title/Position: Founder and CEOCompany/Affiliation: CuretopiaGuest's Bio: Dr. Ethan Perlstein is a scientist, builder, and investor with a focus on developing cures for rare genetic diseases. He is the founder and CEO of Curetopia, a company utilizing innovative approaches to drug development and funding.Links and Resources:Curetopia Website: https://www.curetopia.xyz/Curetopia on Telegram: https://t.me/curetopiaCuretopia on X (Twitter): https://x.com/endrarediseasesKey Takeaways/Highlights:Dr. Perlstein's background as a scientist and his transition into building and investing in biotech companies.The challenges and misconceptions surrounding rare diseases, including their prevalence and the lack of financial incentive for research.Dr. Perlstein's motivation for focusing on rare diseases, inspired by his interaction with parents of affected children.Curetopia's mission to end rare diseases through innovative drug development strategies.The potential of blockchain and Web3 technologies to transform drug development, including funding, data sharing, and community engagement.Dr. Perlstein's vision for a more collaborative and accelerated approach to finding cures for rare diseases.

In this episode, we interview Kerchanin Allen, a marketing expert with ten years of experience in the healthcare industry. Kerchanin discusses her journey from journalism to healthcare marketing, sharing insights on the unique challenges and opportunities in this dynamic field. She emphasizes the importance of strategic marketing, storytelling, and adapting to the evolving landscape of healthcare, including the use of AI.Chapters/Timestamps:00:00 - Introduction and Kerchanin Allen's Background 09:02 - Strategic Marketing and Storytelling 21:25 - Marketing to Diverse Audiences 31:54 - AI in Healthcare Marketing 40:09 - Sales and Marketing Alignment 47:04 - Advice for Healthcare Marketers and Final Thoughts Guest Information:Guest's Name: Kerchanin AllenGuest's Title/Position: Marketing ExpertGuest's Linkedin: https://www.linkedin.com/in/kerchanina/Guest's Bio: Kerchanin Allen is a marketing expert with over ten years of experience implementing marketing strategies for organizations in the healthcare space. Her experience spans payer level, utilization management, care coordination, and ACO REACH. Key Takeaways/Highlights:Kerchanin Allen's background in journalism and how it informs her approach to marketing. The importance of strategic versus cosmetic marketing in healthcare. Challenges and strategies for marketing to diverse audiences (patients, providers, investors). The role of storytelling and creating cohesive brand narratives. Navigating compliance and legal considerations in healthcare marketing. The impact of AI on marketing and its potential in the healthcare sector. The importance of collaboration between sales and marketing teams. Advice for healthcare marketers: be adaptable, embrace calculated risks, and be persistent.

In this episode, we interview Jessica Gibson, CEO and co-founder of Aerial Precision Medicine, about the company's innovative approach to precision medicine. Jessica discusses her journey from studying emergency medicine to leading a company that's using genetics and AI to transform the diagnosis and treatment of chronic diseases. She highlights the importance of addressing the root cause of diseases, the challenges of navigating the healthcare system, and Aerial's work in developing targeted therapies to improve patient outcomes.Chapters/Timestamps:00:00 - Introduction and Jessica Gibson's Background08:50 - Ariel Precision Medicine and its Mission21:25 - The Role of AI and Technology in Precision Medicine31:54 - Addressing Challenges in Healthcare and Drug Development40:09 - Marketing and Collaboration Strategies47:04 - Jessica Gibson's Vision for the Future of Aerial Precision MedicineGuest Information:Guest's Name: Jessica GibsonGuest's Title/Position: CEO and CofounderGuest's Company/Affiliation: Aerial Precision MedicineGuest's Bio: Jessica Gibson is the CEO and co-founder of Aerial Precision Medicine. With a background in medicine and science, she transitioned into business and management to drive innovation in healthcare and improve patient outcomes.Links and Resources:Aerial Precision Medicine Website: https://arielmedicine.com/Jessica Gibson LinkedIn: https://www.linkedin.com/in/jessica-gibson-80426124National Pancreas Foundation: https://nationalpancreasfoundations.org/Rebecca's Wish: https://rebeccaswish.org/Mission Cure: https://mission-cure.org/Key Takeaways/Highlights:Jessica Gibson's journey from emergency medicine and gastroenterology research to leading Aerial Precision Medicine.Aerial Precision Medicine's focus on using genetics and AI to understand the root causes of chronic diseases.The challenges of the "diagnostic odyssey" for patients with digestive and metabolic diseases.How Aerial Precision Medicine's technology helps to streamline the diagnosis process and personalize treatment plans.The importance of data quality and human oversight in the use of AI in healthcare.Aerial Precision Medicine's approach to drug development, starting with a deep understanding of the disease.The company's emphasis on collaboration with healthcare providers, researchers, and pharmaceutical companies.Jessica Gibson's insights on leadership, company growth, and navigating the complexities of the healthcare industry.

In this episode, we interview Joe Banach, Director of Sales and Marketing at Next Step Robotics, about the innovative use of robotics in rehabilitation. Joe shares his unique career path from personal trainer and physical therapist to the health tech industry. He discusses Next Step Robotics' approach to rehabilitation, emphasizing patient contribution to movement and the importance of data-driven outcomes. Joe also provides insights into the challenges of marketing novel technology in the healthcare space and strategies for overcoming them.Chapters/Timestamps:00:00 - Introduction and Joe's Background02:59 - Next Step Robotics and the AMBL Device05:50 - The Role of Data in Therapy09:02 - Sales and Marketing Strategies in Healthcare12:06 - Challenges in Educating the MarketGuest Information:Guest's Name: Joe BanachGuest's Title/Position: Director of Sales and MarketingGuest's Company/Affiliation: Next Step RoboticsGuest's Bio: Joe Banach is the Director of Sales and Marketing at Next Step Robotics. With a background as a physical therapist, Joe is dedicated to advancing rehabilitation through the use of innovative robotic technology and improving patient outcomes.Links and Resources:Next Step Robotics Website: www.nextsteprobo.comLinkedIn: https://www.linkedin.com/in/joseph-banach-pt-dpt-ocs/Book Recommendation: The Sales Acceleration Formula by Mark RobergeBook Recommendation: Never Split The Difference by Chris VossKey Takeaways/Highlights:Joe Banach's unconventional journey from personal trainer to Director of Sales and Marketing.Next Step Robotics' AMBL device and its focus on patient-contributed movement.The importance of supplementing traditional therapy with robotic technology to increase dosage and improve outcomes.The role of neuroplasticity and cognitive engagement in effective rehabilitation.Using data and gamification to motivate patients and track progress.Challenges in educating the market and building trust for new rehabilitation technologies.Sales strategies for navigating long sales cycles and competing in the health tech industry.The impact of therapist turnover on the adoption of new technologies in rehab clinics.

Join host Heath Fletcher on The Healthy Enterprise as he explores how healthcare leaders and innovators are transforming the industry from the inside out. Whether you’re a provider, tech entrepreneur, marketing strategist, or industry executive, these conversations deliver actionable strategies, innovative solutions, and human-centered insights to help you grow, lead, and make a lasting impact.This podcast was created and produced by Bullzeye Media Marketing. Let’s make something great together!